OraVerse is one of 4 small molecule programs targeting Local Anesthesia. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
4 competitors in Local Anesthesia
Ketalar
Benadryl
OraVerse
Lidocaine Epinephrine
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details